Hung David - Feb 28, 2022 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role
President and CEO, Director, 10%+ Owner
Signature
David Hung, by /s/ Kris Tsao Cachia, Attorney-in-Fact
Stock symbol
NUVB
Transactions as of
Feb 28, 2022
Transactions value $
$0
Form type
4
Date filed
3/2/2022, 01:29 PM
Previous filing
Jun 11, 2021
Next filing
Jun 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NUVB Class A Common Stock 58.6M Feb 28, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVB Stock Option (Right to Buy) Award $0 +2M $0.00 2M Feb 28, 2022 Class A Common Stock 2M $5.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,788 shares acquired on November 19, 2021 under the Issuer's 2021 Employee Stock Purchase Plan.
F2 Option vests as to 25% on the one year anniversary of 2/28/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.